Delivery Order SPE2DR25D2005-SPE2DR26FE7T9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for Thrombin-JMI 5,000 Units Vials with a ceiling value of $22,319.95. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion on November 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,236.16 firm fixed-price contract is for the supply of 4,557,711,596 units of Thrombin-JMI, a 20,000-unit vial medication. The award was made on July 5, 2022, with a completion date of July 6, 2022. This contract is a task order under AmerisourceBergen's larger $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $7,174.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20,000 units of Thrombin-JMI vials. The single day order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Department of Defense's medical supply needs. No additional details were provided regarding the context or purpose of the ordered products. The award utilizes no set-aside designations and does not appear to be associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,357.48 firm-fixed-price delivery order is for the supply of 20,000 unit vials of the thrombin-jmi medication. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024 with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7T9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 20,000 Units Pumps on December 1, 2025, with a ceiling value of $1,488.35 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small-value transaction within the broader medical supply procurement portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through multiple competitively awarded contracts across diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/30/25 |